<DOC>
	<DOCNO>NCT02066298</DOCNO>
	<brief_summary>Because approximately half mild-moderately-severe asthma persistently non-eosinophilic , important determine prospectively patient persistently non-eosinophilic differ benefit inhale corticosteroid treatment compare patient persistently non-eosinophilic .</brief_summary>
	<brief_title>Steroids In Eosinophil Negative Asthma</brief_title>
	<detailed_description>SIENA 42-week randomized , stratify , 3-period double-blind placebo-controlled crossover study patient symptomatic mild-to-moderate asthma , already take inhale corticosteroid , effect `` medium-dose '' inhale corticosteroid ( ICS ) compare effect placebo long-acting muscarinic antagonist ( LMA ) .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Physiciandiagnosed asthma least previous 12 month . Able perform reproducible spirometry . Baseline FEV1≥70 % predict . Asthma confirm either : Betaagonist reversibility 4 puff albuterol ≥ 12 % OR Methacholine PC20 ≤ 16 mg/ml At least 1 follow indication chronic controller therapy : Asthma Symptoms &gt; 2 days/week OR Nocturnal Asthma Symptoms &gt; 2 nights/month OR Shortacting betaagonist use symptom control &gt; 2 days/week For participant ≥18 year age : Ability provide inform consent . For participant 18 year age : Ability provide verbal write assent ability parent provide inform consent . Willingness , female able conceive , utilize one medicallyacceptable form contraception . Chronic inhale oral corticosteroid therapy . Use inhale oral corticosteroid therapy within 6 week . New allergen immunotherapy within past 3 month anticipate change ongoing immunotherapy regimen . Use omalizumab within 3 month . History : bladderneck obstruction , urinary retention benign prostatic hyperplasia narrow angle glaucoma significant cardiovascular disorder arrhythmias lifethreatening asthma require treatment intubation mechanical ventilation within past 5 year Respiratory tract infection within past 6 week . History smoke within past 1 year , &gt; 10 packyears total ≥ 18 year age , &gt; 5 packyears total &lt; 18 year age . Chronic diseases medical condition ( asthma ) could put participant risk participation , e.g . chronic disease lung ( asthma ) , heart , liver , kidney , endocrine nervous system , immunodeficiency .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Mometasone</keyword>
	<keyword>Tiotropium</keyword>
</DOC>